Dr. David Bartlett’s Term as SSO President Begins

David L. Bartlett, MD began his term as President of the Society of Surgical Oncology (SSO) last month at SSO 2019, the 72nd SSO Annual Cancer Symposium. An internationally recognized pioneer in hyperthermic intraperitoneal chemoperfusion (HIPEC) for complex abdominal cancers, Dr. Bartlett’s research centers on the use of oncolytic viruses to simulate immune function.